CSIMarket
 


Sonoma Pharmaceuticals Inc   (SNOA)
Other Ticker:  
 
 

SNOA's Net Cash Flow Growth by Quarter and Year

Sonoma Pharmaceuticals Inc 's Net Cash Flow results by quarter and year




SNOA Net Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter March - 1.19 -1.13 -1.32
III Quarter December 0.27 -0.72 0.14 1.22
II Quarter September -1.41 -2.24 5.58 -0.23
I Quarter June -0.28 -1.81 -1.41 0.86
FY   -1.42 -3.58 3.18 0.53



SNOA Net Cash Flow third quarter 2024 Y/Y Growth Comment
Sonoma Pharmaceuticals Inc in the third quarter 2024 achieved Net Cash Flow of $ 0.27 millions compare to net cash outflow recorded in same quarter a year ago.

According to the results reported in the third quarter 2024, Sonoma Pharmaceuticals Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Sonoma Pharmaceuticals Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter 2024.




SNOA Net Cash Flow ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December - - -88.52 % 144 %
II Quarter September - - - -
I Quarter June - - - 43.33 %
FY   - - 500 % 5200 %

Financial Statements
Sonoma Pharmaceuticals Inc 's third quarter 2024 Net Cash Flow $ 0.27 millions SNOA's Income Statement
Sonoma Pharmaceuticals Inc 's third quarter 2023 Net Cash Flow $ -0.72 millions Quarterly SNOA's Income Statement
New: More SNOA's historic Net Cash Flow Growth >>


SNOA Net Cash Flow (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December - - -97.49 % -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - 500 % 5200 %




Net Cash Flow third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Sonoma Pharmaceuticals Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SNOA's III. Quarter Q/Q Net Cash Flow Comment
This turnaround III. Quarter 2024where Sonoma Pharmaceuticals Inc delivered Net Cash Flow of $ 0.27 millions may be considered as a starting point of positive results.Sonoma Pharmaceuticals Inc announced in the III. Quarter 2024 Net Cash Flow of $ 0.27 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Sonoma Pharmaceuticals Inc achieved highest sequential Net Cash Flow growth. While Sonoma Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SNOA's III. Quarter Q/Q Net Cash Flow Comment
This reversal of fortune III. Quarter 2024where Sonoma Pharmaceuticals Inc published Net Cash Flow of $ 0.27 millions should is inception of better business climet.Sonoma Pharmaceuticals Inc announced in the III. Quarter 2024 Net Cash Flow of $ 0.27 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Sonoma Pharmaceuticals Inc achieved highest sequential Net Cash Flow growth. While Sonoma Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Sonoma Pharmaceuticals Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -0.23 $ -1.21 $ -2.04 $ -3.58 $ -5.90
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Sonoma Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Sonoma Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
SNOA's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for SNOA's Competitors
Net Cash Flow Growth for Sonoma Pharmaceuticals Inc 's Suppliers
Net Cash Flow Growth for SNOA's Customers

You may also want to know
SNOA's Annual Growth Rates SNOA's Profitability Ratios SNOA's Asset Turnover Ratio SNOA's Dividend Growth
SNOA's Roe SNOA's Valuation Ratios SNOA's Financial Strength Ratios SNOA's Dividend Payout Ratio
SNOA's Roa SNOA's Inventory Turnover Ratio SNOA's Growth Rates SNOA's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Macrogenics Inc -55.57%$ -55.574 millions
Atricure Inc -59.98%$ -59.983 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com